Shuttle Pharmaceuticals, Inc. Presentation @ Lytham Partners Spring 2024 Investor Conference
As part of the Lytham Partners Spring 2024 Investor Conference, Robert Blum, Managing Partner, Lytham Partners, hosted a Virtual Webcast Presentation with Shuttle Pharmaceuticals, Inc.
Founded in 2012 by faculty members of the Georgetown University Medical Center, Shuttle Pharma is a discovery and development stage specialty pharmaceutical company focused on improving the outcomes for cancer patients treated with radiation therapy (RT).
For more information on our Virtual Investor Conferences, visit https://lythampartners.com/virtual/
Please read our disclaimer/disclosure statement at https://lythampartners.com/disclosures/.